文献速递心血管US

继发性二尖瓣反流患者MitraClip植入后二尖瓣叶重塑不足与瓣环扩张及残余二尖瓣反流风险的关系

Insufficient Mitral Leaflet Remodeling in Relation to Annular Dilation and Risk of Residual Mitral Regurgitation After MitraClip Implantation.
PubMed 文献 · JACC Cardiovasc Imaging · 2020-10-28

本研究纳入119例接受MitraClip治疗的继发性二尖瓣反流患者,用三维经食管超声测量二尖瓣叶总面积与瓣环面积比值(TLA/MAA)。36%患者术后存在显著残余反流(≥2+);残余反流组TLA/MAA较低(1.14±0.15 vs 1.34±0.16,p<0.001),且TLA/MAA识别残余反流的AUC优于单纯瓣环面积(0.830 vs 0.723,p=0.049)。

要点

  • 继发性二尖瓣反流患者中,术后显著残余反流(≥2+)者TLA/MAA比值更低。
  • TLA/MAA识别显著残余反流的AUC为0.830,优于MAA的0.723。
  • 术后残余反流组二尖瓣环面积大于无残余反流组,而瓣叶总面积无显著差异。

核心结论

  • 在继发性二尖瓣反流患者中,二尖瓣叶重塑相对瓣环扩张不足(表现为较低的TLA/MAA比值)与MitraClip植入后显著残余二尖瓣反流相关。

研究设计与样本

  • 研究纳入119例接受MitraClip治疗的继发性二尖瓣反流患者,平均年龄74±9岁,男性占61%。
  • 采用三维经食管超声数据集,用专用软件测量舒张期二尖瓣叶总面积和收缩期二尖瓣环面积,并计算TLA/MAA比值。

关键影像表现/征象

  • 显著残余反流(≥2+)患者43例(36%)。
  • 残余反流组二尖瓣环面积大于无残余反流组(10.7±2.4 cm2 vs 9.0±2.1 cm2,p<0.001),而两组二尖瓣叶总面积无显著差异(12.2±2.6 cm2 vs 12.0±2.9 cm2,p=0.836)。
  • 残余反流组TLA/MAA比值低于无残余反流组(1.14±0.15 vs 1.34±0.16,p<0.001),提示瓣叶重塑相对瓣环扩张不足。

诊断标准与关键数值

  • 显著残余二尖瓣反流定义为反流程度≥2+。
  • TLA/MAA比值识别显著残余反流的AUC为0.830,二尖瓣环面积单独识别的AUC为0.723(p=0.049)。

临床应用与阅片要点

  • 对继发性二尖瓣反流患者行MitraClip术前评估时,可在三维经食管超声中测量舒张期二尖瓣叶总面积与收缩期二尖瓣环面积并计算TLA/MAA比值。
  • TLA/MAA比值较低提示瓣叶重塑相对瓣环扩张不足,可能与术后显著残余反流相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The purpose of this study was to determine whether the mitral valve (MV) total leaflet area (TLA)-to-mitral annular area (MAA) (TLA/MAA) ratio measured using 3-dimensional (3D) transesophageal echocardiography (TEE) was associated with residual mitral regurgitation (MR) after MitraClip implantation in patients with secondary MR.

BACKGROUND: The factors influencing the results of MitraClip implantation for secondary MR are controversial. This study hypothesized that insufficient remodeling of the mitral leaflets relative to the annular dilation may be associated with significant MR after MitraClip implantation.

METHODS: This study included patients with secondary MR treated with MitraClips. Using 3D TEE dataset, the TLA in diastole and MAA in systole were measured with dedicated software.

RESULTS: In a total cohort of 119 patients (mean age 74 ± 9 years; 61% male), significant residual MR (≥2+) was present in 43 patients (36%). In patients with significant residual MR, MAA was greater than in patients without residual MR (10.7 ± 2.4 cm2 vs. 9.0 ± 2.1 cm2; p < 0.001) whereas no significant difference was observed in TLA (12.2 ± 2.6 cm2 vs. 12.0 ± 2.9 cm2; p = 0.836). TLA/MAA ratio was lower in patients with significant residual MR as compared to their counterparts (1.14 ± 0.15 vs. 1.34 ± 0.16; p < 0.001), suggesting insufficient leaflet remodeling relative to annular dilation. On receiver-operating characteristic curve analysis, the TLA/MAA ratio had better discriminative power to identify patients who will have significant residual MR compared to MAA alone (area under the curve [AUC]: 0.830 vs. 0.723; p = 0.049).

CONCLUSIONS: In patients with secondary MR, insufficient mitral leaflet remodeling relative to the annulus dilation, as reflected by a lower TLA/MAA ratio, is associated with significant residual MR after MitraClip implantation.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Hirasawa K, Namazi F, Milhorini Pio S, et al. Insufficient Mitral Leaflet Remodeling in Relation to Annular Dilation and Risk of Residual Mitral Regurgitation After MitraClip Implantation. JACC Cardiovasc Imaging. 2020. PMID: 33129743. doi:10.1016/j.jcmg.2020.08.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。